/ JNJ
Johnson & Johnson Posts Strong Q3 with $5.15B Net Earnings, Lifts 2025 Outlook
J&J posted $24B in Q3 sales and $2.80 adjusted EPS, beating estimates and raising full-year guidance.
October 14, 2025Johnson & Johnson (JNJ) Outperforms Q2 Expectations; Provides Positive Outlook
Johnson & Johnson (JNJ) surpassed expectations in Q2 2025 with a notable increase in earnings per share and revenue.
July 16, 2025Johnson & Johnson (JNJ) Reports Strong Q1 Performance
Johnson & Johnson's first-quarter results surpassed expectations with notable growth in sales and earnings.
April 15, 2025J&J Stock Dips After $10 Billion Settlement Dismissed by Judge
Johnson & Johnson faces a significant legal setback with the dismissal of its $10 billion settlement proposal related to talc product lawsuits.
April 01, 2025Activist Investor Starboard Acquires Stake in Band-Aid Maker Kenvue, Shares Jump
Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.
October 21, 2024